Featured Event
Nov 10, 2011
Listen to the presentation of Interim Report for the 3D Quarter

Business Development

Veloxis believes that collaboration and partnerships are essential to growing a successful specialty pharmaceutical business. Veloxis is actively seeking to build long-term win-win relationships with partners through in-licensing, out-licensing, and collaborations in the transplantation, immunosuppression, and other specialty therapeutic fields. As a small, focused company, our Business Development professionals can work efficiently to quickly evaluate and creatively negotiate and manage alliances across the pharmaceuticals value chain. The Veloxis goal is to fully understand each partner's strategic objectives and to strive to develop creative alliance approaches that meet our respective interests and needs, thus allowing us to become your partner of choice.

Please contact:

Edward E. Koval
Senior Vice President
Business and Strategic Corporate Development
Veloxis Pharmaceuticals A/S
499 Thornall Street
Edison, NJ 08837
US